← Back to directory

Hideo Baba

Researcher Next ID · RN-035856

Researcher · Medicine

Kumamoto University Hospital

Kumamoto, Japan

Accepting doctoral researchersFunding unknown
Works count
1,251
Citation count
36,143
H-index
88
i10-index
544

Research interests

Medicine
Gastric Cancer Management and Outcomes
Colorectal Cancer Treatments and Studies
Esophageal Cancer Research and Treatment
Hepatocellular Carcinoma Treatment and Prognosis
Cholangiocarcinoma and Gallbladder Cancer Studies

Publications

  • Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

    Nature Medicine · 2018 · https://doi.org/10.1038/s41591-018-0022-x

  • Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer

    British journal of surgery · 2018 · https://doi.org/10.1002/bjs.10776

  • Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

    The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)31257-1

  • CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy

    Cancer Treatment Reviews · 2017 · https://doi.org/10.1016/j.ctrv.2017.11.007

  • Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells

    Gastroenterology · 2017 · https://doi.org/10.1053/j.gastro.2017.03.046

  • Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location

    Clinical and Translational Gastroenterology · 2016 · https://doi.org/10.1038/ctg.2016.53

  • Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor Resection

    Diseases of the Colon & Rectum · 2015 · https://doi.org/10.1097/dcr.0000000000000458

  • Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study

    Journal of Hepato-Biliary-Pancreatic Sciences · 2015 · https://doi.org/10.1002/jhbp.276

  • Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial

    The Lancet Oncology · 2013 · https://doi.org/10.1016/s1470-2045(13)70490-x

  • Sarcopenia is a prognostic factor in living donor liver transplantation

    Liver Transplantation · 2013 · https://doi.org/10.1002/lt.23811

  • Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study

    Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2012.43.3680

  • Clinical impact of serum exosomal microRNA‐21 as a clinical biomarker in human esophageal squamous cell carcinoma

    Cancer · 2012 · https://doi.org/10.1002/cncr.27895

  • A nomogram predicting disease‐free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery

    Journal of Hepato-Biliary-Pancreatic Sciences · 2011 · https://doi.org/10.1007/s00534-011-0460-z

  • CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth

    Cancer Cell · 2011 · https://doi.org/10.1016/j.ccr.2011.01.038

  • Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study)

    The Lancet Oncology · 2010 · https://doi.org/10.1016/s1470-2045(10)70181-9

  • Activation of PI3K/Akt signaling and hormone resistance in breast cancer

    Breast Cancer · 2006 · https://doi.org/10.2325/jbcs.13.137

  • Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients

    International Journal of Cancer · 2005 · https://doi.org/10.1002/ijc.21358

  • Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer

    International Journal of Cancer · 2005 · https://doi.org/10.1002/ijc.21170

Current projects

    No projects listed.